O'Shaughnessy Asset Management, LLC Lexicon Pharmaceuticals, Inc. Transaction History

O'Shaughnessy Asset Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$3.81 - $6.16 $5,391 - $8,716	-1,415 Closed	0 $0
Q3 2021 Nov 10, 2021	SELL	$3.38 - $5.35 $17,346 - $27,456	-5,132 Reduced 78.39%	1,415 $7,000
Q2 2021 Aug 09, 2021	SELL	$4.12 - $5.87 $104,957 - $149,538	-25,475 Reduced 79.55%	6,547 $30,000
Q1 2021 May 14, 2021	BUY	$3.45 - $9.09 $69,776 - $183,845	20,225 Added 171.44%	32,022 $188,000
Q4 2020 Feb 11, 2021	SELL	$1.05 - $3.67 $3,981 - $13,916	-3,792 Reduced 24.32%	11,797 $40,000
Q3 2020 Nov 12, 2020	BUY	$1.44 - $2.1 $11,911 - $17,371	8,272 Added 113.05%	15,589 $22,000
Q2 2020 Aug 13, 2020	BUY	$1.75 - $2.3 $9,434 - $12,399	5,391 Added 279.91%	7,317 $15,000
Q1 2020 May 13, 2020	BUY	$1.8 - $4.28 $3,466 - $8,243	1,926 New	1,926 $4,000

141

238M

459K

133K

Ticker LXRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,726,000
Market Cap $170M
Description
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...

Get notified when there are updates to the investment portfolio of O'Shaughnessy Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on O'Shaughnessy Asset Management, LLC with notifications on news.